Press Releases Archives

Agendia Demonstrates MammaPrint Utility in Predicting Chemotherapy Benefit Over 5 Years in Patients with HR+HER2- Early Breast Cancer at SABCS 2024
Gallery
Agendia Demonstrates MammaPrint Utility in Predicting Chemotherapy Benefit Over 5 Years in Patients with HR+HER2- Early Breast Cancer at SABCS 2024

Press Releases

Agendia Demonstrates MammaPrint Utility in Predicting Chemotherapy Benefit Over 5 Years in Patients with HR+HER2- Early Breast Cancer at SABCS 2024

New data reinforces findings from MINDACT supporting MammaPrint® in Read More

Agendia2025-04-17T13:43:47-04:00December 11th, 2024|Press Releases|

Agendia Announces Publication Validating MammaPrint Utility in Prediction of Extended Endocrine Therapy Benefit
Gallery
Agendia Announces Publication Validating MammaPrint Utility in Prediction of Extended Endocrine Therapy Benefit

Press Releases

Agendia Announces Publication Validating MammaPrint Utility in Prediction of Extended Endocrine Therapy Benefit

A secondary analysis of the randomized controlled trial, IDEAL, Read More

Agendia2025-04-17T13:44:21-04:00December 2nd, 2024|Press Releases|

Agendia to Unveil New Findings in Early-Stage Breast Cancer at San Antonio Breast Cancer Symposium 2024
Gallery
Agendia to Unveil New Findings in Early-Stage Breast Cancer at San Antonio Breast Cancer Symposium 2024

Press Releases

Agendia to Unveil New Findings in Early-Stage Breast Cancer at San Antonio Breast Cancer Symposium 2024

New data reinforces MammaPrint® and BluePrint® tests’ expanding clinical Read More

Agendia2025-04-17T13:46:07-04:00November 25th, 2024|Press Releases|

Agendia Co-Founder Prof. Dr. Laura van’t Veer Honored at Three Prestigious Breast Cancer Symposia in Italy, the Netherlands and the U.S. for Pioneering Work in Breast Cancer Diagnostics
Gallery
Agendia Co-Founder Prof. Dr. Laura van’t Veer Honored at Three Prestigious Breast Cancer Symposia in Italy, the Netherlands and the U.S. for Pioneering Work in Breast Cancer Diagnostics

Press Releases

Agendia Co-Founder Prof. Dr. Laura van’t Veer Honored at Three Prestigious Breast Cancer Symposia in Italy, the Netherlands and the U.S. for Pioneering Work in Breast Cancer Diagnostics

IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS, November 14, 2024 Read More

Agendia2025-04-17T13:47:06-04:00November 14th, 2024|Press Releases|

Agendia’s FLEX Study Reaches Enrollment of Over 17,000 Early-Stage Breast Cancer Patients Across Diverse Population
Gallery
Agendia’s FLEX Study Reaches Enrollment of Over 17,000 Early-Stage Breast Cancer Patients Across Diverse Population

Press Releases

Agendia’s FLEX Study Reaches Enrollment of Over 17,000 Early-Stage Breast Cancer Patients Across Diverse Population

This achievement highlights the remarkable seven-year progression of FLEX Read More

Agendia2025-04-17T13:48:18-04:00September 12th, 2024|Press Releases|

Agendia Achieves CE-IVDR Certification
Gallery
Agendia Achieves CE-IVDR Certification

Press Releases

Agendia Achieves CE-IVDR Certification

Agendia Achieves CE-IVDR Certification for its MammaPrint and BluePrint Breast Cancer Assays

Read More

Agendia2024-08-27T13:41:02-04:00August 16th, 2024|Press Releases|

Agendia Announces JCO Publication on MammaPrint Utility in NRG/NSABP B-42 Trial
Gallery
Agendia Announces JCO Publication on MammaPrint Utility in NRG/NSABP B-42 Trial

Press Releases

Agendia Announces JCO Publication on MammaPrint Utility in NRG/NSABP B-42 Trial

MammaPrint 70-gene Assay Evaluated in the NRG Oncology/NSABP B-42 Trial

Read More

Karen Guzdzial2025-04-17T13:53:47-04:00July 30th, 2024|Press Releases|

MammaPrint High 2 tumors exhibit heightened immune active state
Gallery
MammaPrint High 2 tumors exhibit heightened immune active state

Press Releases

MammaPrint High 2 tumors exhibit heightened immune active state

Elucidating the immune active state of HR+HER2- MammaPrint High 2 early breast cancer

Read More

Karen Guzdzial2025-04-17T13:53:40-04:00May 31st, 2024|Press Releases|

MammaPrint & 3-year outcome of CT with/without anthracycline-ASCO 2024
Gallery
MammaPrint & 3-year outcome of CT with/without anthracycline-ASCO 2024

Press Releases

MammaPrint & 3-year outcome of CT with/without anthracycline-ASCO 2024

Association of MammaPrint index and 3-year outcome of patients in the FLEX Registry trial with HR+HER2- early-stage breast cancer treated with chemotherapy with or without anthracycline

Read More

Karen Guzdzial2025-05-06T14:53:23-04:00May 31st, 2024|Press Releases|

Agendia to Unveil Robust Suite of Data at 2024 ASCO
Gallery
Agendia to Unveil Robust Suite of Data at 2024 ASCO

Press Releases

Agendia to Unveil Robust Suite of Data at 2024 ASCO

Agendia to Unveil Robust Suite of Data at 2024 ASCO to Further Advance Breast Cancer Care

Read More

Karen Guzdzial2025-04-17T13:54:40-04:00May 24th, 2024|Press Releases|

Cookie	Duration	Description
__cf_bm	1 hour	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.
_ga	1 year 1 month 4 days	Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.
_ga_*	1 year 1 month 4 days	Google Analytics sets this cookie to store and count page views.
c	6 months 2 days	Rubicon Project sets this cookie to control the synchronization of user identification and the exchange of user data between various ad services.
CookieLawInfoConsent	1 year	CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie.
rc::a	never	This cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
rc::c	session	This cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
uuid	1 year 1 month	MediaMath sets this cookie to avoid the same ads from being shown repeatedly and for relevant advertising.
viewed_cookie_policy	1 year	The GDPR Cookie Consent plugin sets the cookie to store whether or not the user has consented to use cookies. It does not store any personal data.
VISITOR_INFO1_LIVE	6 months	YouTube sets this cookie to measure bandwidth, determining whether the user gets the new or old player interface.
VISITOR_PRIVACY_METADATA	6 months	YouTube sets this cookie to store the user's cookie consent state for the current domain.
YSC	session	Youtube sets this cookie to track the views of embedded videos on Youtube pages.
yt-remote-cast-installed	session	The yt-remote-cast-installed cookie is used to store the user's video player preferences using embedded YouTube video.
yt-remote-connected-devices	never	YouTube sets this cookie to store the user's video preferences using embedded YouTube videos.
yt-remote-device-id	never	YouTube sets this cookie to store the user's video preferences using embedded YouTube videos.
yt-remote-fast-check-period	session	The yt-remote-fast-check-period cookie is used by YouTube to store the user's video player preferences for embedded YouTube videos.
yt-remote-session-app	session	The yt-remote-session-app cookie is used by YouTube to store user preferences and information about the interface of the embedded YouTube video player.
yt-remote-session-name	session	The yt-remote-session-name cookie is used by YouTube to store the user's video player preferences using embedded YouTube video.
yt.innertube::nextId	never	YouTube sets this cookie to register a unique ID to store data on what videos from YouTube the user has seen.
yt.innertube::requests	never	YouTube sets this cookie to register a unique ID to store data on what videos from YouTube the user has seen.
ytidb::LAST_RESULT_ENTRY_KEY	never	The cookie ytidb::LAST_RESULT_ENTRY_KEY is used by YouTube to store the last search result entry that was clicked by the user. This information is used to improve the user experience by providing more relevant search results in the future.

Cookie	Duration	Description
__cf_bm	1 hour	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.
CookieLawInfoConsent	1 year	CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie.
rc::a	never	This cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
rc::c	session	This cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
viewed_cookie_policy	1 year	The GDPR Cookie Consent plugin sets the cookie to store whether or not the user has consented to use cookies. It does not store any personal data.

Cookie	Duration	Description
c	6 months 2 days	Rubicon Project sets this cookie to control the synchronization of user identification and the exchange of user data between various ad services.
uuid	1 year 1 month	MediaMath sets this cookie to avoid the same ads from being shown repeatedly and for relevant advertising.
VISITOR_INFO1_LIVE	6 months	YouTube sets this cookie to measure bandwidth, determining whether the user gets the new or old player interface.
VISITOR_PRIVACY_METADATA	6 months	YouTube sets this cookie to store the user's cookie consent state for the current domain.
YSC	session	Youtube sets this cookie to track the views of embedded videos on Youtube pages.
yt.innertube::nextId	never	YouTube sets this cookie to register a unique ID to store data on what videos from YouTube the user has seen.
yt.innertube::requests	never	YouTube sets this cookie to register a unique ID to store data on what videos from YouTube the user has seen.

Cookie	Duration	Description
_ga	1 year 1 month 4 days	Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.
_ga_*	1 year 1 month 4 days	Google Analytics sets this cookie to store and count page views.

Cookie	Duration	Description
yt-remote-cast-installed	session	The yt-remote-cast-installed cookie is used to store the user's video player preferences using embedded YouTube video.
yt-remote-connected-devices	never	YouTube sets this cookie to store the user's video preferences using embedded YouTube videos.
yt-remote-device-id	never	YouTube sets this cookie to store the user's video preferences using embedded YouTube videos.
yt-remote-fast-check-period	session	The yt-remote-fast-check-period cookie is used by YouTube to store the user's video player preferences for embedded YouTube videos.
yt-remote-session-app	session	The yt-remote-session-app cookie is used by YouTube to store user preferences and information about the interface of the embedded YouTube video player.
yt-remote-session-name	session	The yt-remote-session-name cookie is used by YouTube to store the user's video player preferences using embedded YouTube video.
ytidb::LAST_RESULT_ENTRY_KEY	never	The cookie ytidb::LAST_RESULT_ENTRY_KEY is used by YouTube to store the last search result entry that was clicked by the user. This information is used to improve the user experience by providing more relevant search results in the future.